公司资料
VBI Vaccines 股价、新闻与催化剂
已退市
- 股票代码:
- VBIV
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
目前无法获取 VBIV 的收盘价变动背景。
公司概览
业务概览
VBI Vaccines is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, VBI Vaccines is followed within the infectious-disease universe for its exposure to vaccine and antiviral catalysts.
商业模式特征
VBI Vaccines combines program development with demand-sensitive launch execution, so investors usually track efficacy, safety, and the commercial path for each major asset.
生物医药行业定位
Compared with broader biotech peers, VBI Vaccines sits in a catalyst-heavy corner of the landscape where virus, vaccine, and antiviral updates can move sentiment quickly.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。